More on QNTM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Quantum BioPharma (NQ:QNTM)
Delayed: 2.37 +0.05 (2.16%)
Prev. Close $2.32  
Open$2.42 
52 Wk High$2.00 
52 Wk Low$0.10 
Day High$2.42 
Day Low$2.35 
P/E N/A  
EPS$0.00 
Volume103,350 

Friends, Peers and Foes (?): 0K91, BIIB, CLNN, SNY, BMY (more...)

Oct 8, 2026 08:00 AM Form 6-K Quantum Biopharma Ltd. For: Oct 08
Oct 8, 2026 08:00 AM World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quant
Oct 8, 2026 08:00 AM World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum B
Oct 6, 2026 06:03 AM Form 6-K Quantum Biopharma Ltd. For: Oct 06
Oct 6, 2026 06:00 AM Quantum BioPharma signs Thermo Fisher deal for MS Phase 2 trial
Oct 6, 2026 06:00 AM Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
Oct 5, 2026 09:40 AM Form SCHEDULE 13G/A Quantum Biopharma Ltd. Filed by: AdvisorShares Trust
Sep 30, 2026 08:00 AM IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
Sep 24, 2026 08:01 AM Quantum BioPharma licensee Unbuzzd names new CEO, eyes stock listing
Sep 24, 2026 08:00 AM Form 6-K Quantum Biopharma Ltd. For: Sep 24
View All Articles

Entities mentioned with QNTM

View All Entities